Cargando…

Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data

As a condition, diabetes mellitus is associated with risk factors and diseases such as obesity. At the same time, cardiovascular diseases are a frequent consequence of diabetes. There have yet to be any findings on the Germany-wide prevalence of diabetes and diabetes comorbidities based on statutory...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Christian, Reitzle, Lukas, Paprott, Rebecca, Bätzing, Jörg, Holstiege, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Robert Koch Institute 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734101/
https://www.ncbi.nlm.nih.gov/pubmed/35146307
http://dx.doi.org/10.25646/8327
_version_ 1784627944152367104
author Schmidt, Christian
Reitzle, Lukas
Paprott, Rebecca
Bätzing, Jörg
Holstiege, Jakob
author_facet Schmidt, Christian
Reitzle, Lukas
Paprott, Rebecca
Bätzing, Jörg
Holstiege, Jakob
author_sort Schmidt, Christian
collection PubMed
description As a condition, diabetes mellitus is associated with risk factors and diseases such as obesity. At the same time, cardiovascular diseases are a frequent consequence of diabetes. There have yet to be any findings on the Germany-wide prevalence of diabetes and diabetes comorbidities based on statutory health insurance data. This study estimates the documented prevalence of diabetes in 2019 on the basis of all ambulatory physicians’ claims data of German statutory health insurance. In addition, the prevalence of obesity, high blood pressure, coronary heart disease, heart failure, stroke and depression is calculated for diabetes and non-diabetes patients, and the prevalence ratio (PR) is determined as a quotient. The approach used was a case-control design, which assigns a control person without diabetes to each diabetes patient who is similar in terms of age, region and sex. In diabetes patients, a PR greater than 1 was observed for all examined diseases across all age groups, thus demonstrating a higher prevalence compared to persons without diabetes. The highest PR across all age groups for women (3.8) and men (3.7) was found for obesity. In a comparison over time, documented prevalence figures of diabetes in Germany stagnate. With the exception of depression, the documented prevalences of comorbidities correspond well with the prevalences found in population-wide examination surveys.
format Online
Article
Text
id pubmed-8734101
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Robert Koch Institute
record_format MEDLINE/PubMed
spelling pubmed-87341012022-02-09 Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data Schmidt, Christian Reitzle, Lukas Paprott, Rebecca Bätzing, Jörg Holstiege, Jakob J Health Monit Focus As a condition, diabetes mellitus is associated with risk factors and diseases such as obesity. At the same time, cardiovascular diseases are a frequent consequence of diabetes. There have yet to be any findings on the Germany-wide prevalence of diabetes and diabetes comorbidities based on statutory health insurance data. This study estimates the documented prevalence of diabetes in 2019 on the basis of all ambulatory physicians’ claims data of German statutory health insurance. In addition, the prevalence of obesity, high blood pressure, coronary heart disease, heart failure, stroke and depression is calculated for diabetes and non-diabetes patients, and the prevalence ratio (PR) is determined as a quotient. The approach used was a case-control design, which assigns a control person without diabetes to each diabetes patient who is similar in terms of age, region and sex. In diabetes patients, a PR greater than 1 was observed for all examined diseases across all age groups, thus demonstrating a higher prevalence compared to persons without diabetes. The highest PR across all age groups for women (3.8) and men (3.7) was found for obesity. In a comparison over time, documented prevalence figures of diabetes in Germany stagnate. With the exception of depression, the documented prevalences of comorbidities correspond well with the prevalences found in population-wide examination surveys. Robert Koch Institute 2021-06-16 /pmc/articles/PMC8734101/ /pubmed/35146307 http://dx.doi.org/10.25646/8327 Text en © Robert Koch Institute. All rights reserved unless explicitly granted. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Focus
Schmidt, Christian
Reitzle, Lukas
Paprott, Rebecca
Bätzing, Jörg
Holstiege, Jakob
Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title_full Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title_fullStr Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title_full_unstemmed Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title_short Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
title_sort diabetes mellitus and comorbidities – a cross-sectional study with control group based on nationwide ambulatory claims data
topic Focus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734101/
https://www.ncbi.nlm.nih.gov/pubmed/35146307
http://dx.doi.org/10.25646/8327
work_keys_str_mv AT schmidtchristian diabetesmellitusandcomorbiditiesacrosssectionalstudywithcontrolgroupbasedonnationwideambulatoryclaimsdata
AT reitzlelukas diabetesmellitusandcomorbiditiesacrosssectionalstudywithcontrolgroupbasedonnationwideambulatoryclaimsdata
AT paprottrebecca diabetesmellitusandcomorbiditiesacrosssectionalstudywithcontrolgroupbasedonnationwideambulatoryclaimsdata
AT batzingjorg diabetesmellitusandcomorbiditiesacrosssectionalstudywithcontrolgroupbasedonnationwideambulatoryclaimsdata
AT holstiegejakob diabetesmellitusandcomorbiditiesacrosssectionalstudywithcontrolgroupbasedonnationwideambulatoryclaimsdata